← Eichor
Study identifier: NCT05825092 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill

Condition: Critical Illness  ·  Sponsor: University Hospital, Clermont-Ferrand

PhasePhase 2
Planned participants600
Who can joinAll sexes, 18 Years to 79 Years
Healthy volunteersNo

About this study

Critically ill patients experience major insults that lead to increased protein catabolism. Hypermetabolism occurs early and rapidly during the first week of critical illness to provide amino acids for the production of energy via gluconeogenesis, and also for the synthesis of acute phase proteins and repair of tissue damage. During acute phase, neuroendocrine and inflammatory responses promote protein breakdown and amino acid release. Under stress conditions, protein synthesis cannot match the increased rate of muscle proteolysis because of a state of anabolism resistance, which limits uptake of amino acids into muscles. Hypermetabolism results in a significant loss of lean body mass with an impact on weaning from the ventilator and muscle recovery. Functional disability can be long term sometimes with no full return to normal. In critically ill patients, severe and persistent testosterone deficiency is very common and is observed early after Intensive Care Unit (ICU) admission. This acquired hypogonadism promotes the persistent loss of skeletal muscle protein and is related to poor outcome. Administration of testosterone induces skeletal muscle fiber hypertrophy and decreases protein breakdown in healthy young men. It has been repeatedly shown that testosterone treatment enhances muscle mass and strength in hypogonadal men and women and can improve physical performance. Testosterone administration in burned patients reduces protein breakdown and increases protein synthe…

This description comes directly from the study's public registry record.

Talk to the study team

Lise LACLAUTRE  ·  +33473754963  ·  promo_interne_drci@chu-clermontferrand.fr

Always discuss trial participation with your own doctor first.

Locations (5)

Service de Medecine Intensive et Réanimation CHU de Bordeaux Hopital PellegrinBordeaux, FranceNot Yet Recruiting
Service d'Anesthésie et Réanimation Centre Jean-PerrinClermont-Ferrand, FranceRecruiting
Service de Médecine Intensive et Réanimation (MIR), CHU Clermont-FerrandClermont-Ferrand, FranceRecruiting
Service de Médecine Intensive et de Réanimation CHD La Roche sur YonLa Roche-sur-Yon, FranceRecruiting
Service de Médecine Intensive et Réanimation CHU Nantes, Hôtel DieuxNantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05825092